Over the last 7 days, the Life Sciences industry has dropped 1.5%, driven by a pullback from WuXi Biologics (Cayman) of 3.8%. In contrast, WuXi XDC Cayman has gained 13%. Overall the industry is down 67% in 12 months. Earnings are forecast to grow by 39% annually.
Has the Hong Kong Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Apr 2024 | HK$103.9b | HK$33.6b | HK$3.1b | 31.1x | 33.6x | 3.1x |
Sun, 24 Mar 2024 | HK$111.8b | HK$33.2b | HK$3.7b | 52.8x | 30.6x | 3.4x |
Tue, 20 Feb 2024 | HK$120.8b | HK$32.3b | HK$3.0b | 46x | 40.6x | 3.7x |
Thu, 18 Jan 2024 | HK$200.9b | HK$32.3b | HK$3.0b | 85.2x | 67.5x | 6.2x |
Sat, 16 Dec 2023 | HK$212.6b | HK$32.5b | HK$3.0b | 85.1x | 70.3x | 6.5x |
Mon, 13 Nov 2023 | HK$264.4b | HK$30.1b | HK$2.7b | 46.7x | 98.9x | 8.8x |
Wed, 11 Oct 2023 | HK$241.5b | HK$30.1b | HK$2.7b | 42.8x | 90.3x | 8x |
Fri, 08 Sep 2023 | HK$223.8b | HK$30.1b | HK$2.7b | 40x | 84x | 7.4x |
Sun, 06 Aug 2023 | HK$243.1b | HK$28.5b | HK$2.7b | 23.2x | 88.7x | 8.5x |
Tue, 04 Jul 2023 | HK$206.9b | HK$28.4b | HK$2.7b | 20.5x | 76.6x | 7.3x |
Thu, 01 Jun 2023 | HK$214.6b | HK$28.8b | HK$2.8b | 21.7x | 76.9x | 7.5x |
Sat, 29 Apr 2023 | HK$249.3b | HK$29.5b | HK$2.9b | 24.5x | 85.4x | 8.5x |
Mon, 27 Mar 2023 | HK$254.9b | HK$28.9b | HK$2.5b | 23x | 103.7x | 8.8x |
Wed, 22 Feb 2023 | HK$293.5b | HK$26.4b | HK$2.1b | 25.6x | 142.1x | 11.1x |
Fri, 20 Jan 2023 | HK$367.4b | HK$26.6b | HK$2.1b | 27.8x | 172.5x | 13.8x |
Sun, 18 Dec 2022 | HK$275.0b | HK$25.9b | HK$2.0b | 26.9x | 138.6x | 10.6x |
Tue, 15 Nov 2022 | HK$276.4b | HK$25.7b | HK$1.9b | 25.4x | 144.8x | 10.7x |
Thu, 13 Oct 2022 | HK$239.1b | HK$25.6b | HK$1.9b | 19.4x | 127.7x | 9.3x |
Sat, 10 Sep 2022 | HK$343.4b | HK$26.2b | HK$2.0b | 25.8x | 170.5x | 13.1x |
Mon, 08 Aug 2022 | HK$392.3b | HK$22.3b | HK$2.0b | 12.2x | 192.5x | 17.6x |
Wed, 06 Jul 2022 | HK$429.2b | HK$22.4b | HK$2.1b | 15.4x | 206.3x | 19.1x |
Fri, 03 Jun 2022 | HK$300.1b | HK$22.5b | HK$2.1b | 13.8x | 142.9x | 13.3x |
Sun, 01 May 2022 | HK$312.2b | HK$22.7b | HK$2.2b | 14x | 145.1x | 13.8x |
Tue, 29 Mar 2022 | HK$341.8b | HK$22.4b | HK$2.3b | 21.2x | 148.5x | 15.3x |
Thu, 24 Feb 2022 | HK$339.9b | HK$18.8b | HK$2.8b | 21.8x | 119.7x | 18.1x |
Sat, 22 Jan 2022 | HK$461.8b | HK$18.7b | HK$2.8b | 31.4x | 164.1x | 24.7x |
Mon, 20 Dec 2021 | HK$472.8b | HK$18.6b | HK$2.8b | 32.4x | 169x | 25.4x |
Wed, 17 Nov 2021 | HK$554.0b | HK$18.6b | HK$2.8b | 37.2x | 198.4x | 29.8x |
Fri, 15 Oct 2021 | HK$560.6b | HK$18.5b | HK$2.8b | 52.1x | 202.6x | 30.3x |
Sun, 12 Sep 2021 | HK$613.7b | HK$18.4b | HK$2.7b | 51.3x | 223.7x | 33.4x |
Tue, 10 Aug 2021 | HK$659.4b | HK$18.4b | HK$2.7b | 52.5x | 240.3x | 35.9x |
Mon, 03 May 2021 | HK$524.9b | HK$15.7b | HK$1.4b | 47.5x | 363.3x | 33.5x |
363.3x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 3.52% | |
Healthcare | 5.75% | |
Life Sciences | -0.71% | |
Clinical Research and Equipment | -0.71% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2268 WuXi XDC Cayman | HK$20.00 | 13.0% +HK$2.7b | n/a | PE76.9x | |
1873 Viva Biotech Holdings | HK$0.56 | 27.3% +HK$257.0m | -64.1% | PS0.5x | |
8225 China Health Group | HK$0.12 | 10.1% +HK$10.9m | -46.7% | PS5.2x |